The Cancer War

When I wrote about my friend yesterday, I was hesitant to do so. Anyone living with cancer or with a friend or loved one with cancer doesn’t really want to hear bad news. But presenting only the happy stories in the face of cancer isn’t realistic, either. Bear with me as I try to balance all of the truth about this cancer – the wonderful ways people reach out and care, the fascinating new research, cancer survivors who beat the odds, and people with cancer who do not make it.

Today’s blog is a great resource if you want to sit down and read a (free!) book about one man’s successful battle against cancer.

Diagnosed with Mantle Cell Lymphoma in 1997, the soap star Anthona Herrera expected to die. His book details his experiences with autologus bone marrow treatment, his relapse and further treatment, as well as his hope for a cancer-free future. With his onstage persona having survived five almost-fatal incidents, Herrera shows the same wit, perseverance and courage in his own life.

You can download the book, “Cancer War” for free at http://www.thecancerwar.com/. While there you can look a personal photos, a video clip of Herrera testifying for Senator Arlen Specter on the importance of the federal government's support of stem cell research.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap